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Abstract 
This paper attempts to highlight the growth and development of Covid-19 drugs 
and medicine literature and make the quantitative and qualitative assessment by way of 
analyzing various features of research output and Citations impact based on the Web of 
Science database. A total of 6425 publications were published on Covid-19 drugs and 
medicine, which received 313411 Citations during 2020-2021. In all, there were 140 
countries involved in research in Covid-19 drugs and medicine. The most productive 
countries are USA highest share of 1814(28.4%) publications and received 17779 
Citations followed by Peoples Republic of China with 18623 Citations for 986(15.5%) 
publications, Italy with 7418 Citations for 763(12%) publications, India with 3323 
Citations for 617(9.7%) publications, UK with 7178 Citations for 577 publications. Most 
productive Institutions were: Harvard Med School from USA with 102 publications (1175 
Citations), followed by Huazhong Univ Science & Technology with 102 publications (2913 
Citations), University Milan with 82 publications (1430 citations), It noted that 30 
Institutes are registered more than 30 Publications and 25 Institutions are recorded more 
than 1000 Citations. The highly Cited journals are: NEW ENGLAND JOURNAL OF 
MEDICINE with 2623 Citations (ACPP is 163.93) for 16 Publications, NATURE with 1546 
Citations (ACPP is 96.62) for 16 publications, JOURNAL OF BIOMOLECULAR STRUCTURE 
& DYNAMICS with 1476 Citations (ACPP is 9.11) for 162 publications, JAMA-JOURNAL 
OF THE AMERICAN MEDICAL ASSOCIATION with 1365 Citations (ACPP is 39.08) for 35 
publications, and SCIENCE with 1197 Citations (ACPP is 74.81) for 16 publications. The 
study found that 8 source titles registered more than 1000 Citations and most of the 
publications are published in high impact Journals. The paper also reveals the 
collaborating institutions, countries and research. Findings also indicate the publication 
pattern, degree of collaboration as well as the nature of the research activities. 
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INTRODUCTION  
  Over 2403641 people have died from COVID-19 in globally and that 
number continues to growing of confirmed cases with 10,88,22,960 from 223 
countries. Our healthcare system is becoming increasingly strained and people 
are in desperate need of a safe and effective treatment for COVID-19 using Drugs, 
Medicines and Vaccines. Scientists around the world are racing against time to 
find a cure. Hospitals and research labs all over the world are testing many 
different therapies on coronavirus-positive patients in an effort to find a potential 
COVID-19 treatment. There are currently many clinical trials in process to study 
other potential therapies, such as monoclonal antibodies, for COVID-19. 
Researchers are also testing older medications (that are typically used to treat 
other conditions) to see if they are also effective for COVID-19. The scientists are 
actively involved in discovering the hidden facts of the universe and in result 
produce the research work in the form of research papers. The research papers 
are the base for further research. It would not be wrong to say that what is 
produce through research should be evaluated to know the trend as well as value 
of the research. 
Evaluating scientific productivity and influence of different subject areas, 
Countries, authors, institutions etc. is one of the goals of Scientometric studies. 
This impact and influence has been assessed through various indicators 
including number of citations, h-index, and so on. Evaluation and assessment 
plays an important role in decision and policy making about each area of science 
and provide useful information about the situation of that area and its strengths 
and weaknesses. Using quantitative techniques like 
bibliometrics/Scientometrics, different studies have investigated library and 
information science productivity and impact from various aspects during 
different periods of time.  
 
OBJECTIVES OF THE STUDY  
In the present study “Covid-19 Drugs and Medicines: A Scientometric 
Mapping of Research Publications” has following objectives as enumerated 
bellow:  
• Evaluation of the research productivity of Doctors, Scientists/Scholars in 
the field of Covid-19 Drugs and Medicines.  
• Most popular and Highly impact Journals in term of publications and 
Citations.  
• Most productive and Cited Authors.  
• Most Cited Countries and Research Collaborations.  
• Most Cited Institutions.  
• Highly Cited works.  
METHODOLOGY  
Web of Science database (Maintain by Clarivate Analytics) was used for 
retrieving data on Covid-19 drugs and medicine using the search term ‘Covid-19 
drugs’ or ‘Covid-19 medicine’ in ‘topic’ field. Records pertaining to Covid-19 drugs 
and medicine were retrieved only 2020-2021. A total of 6425 publications and 
313411 Citations of collection were exported to Software (Histcite and VOSviwer) 
and analyzed the data as per objectives of the study.  
 
DATA ANALYSIS AND INTERPRETATION 
Geographical wise distribution of publications and Citations 
In all, there were 140 countries involved in research in Covid-19 drugs and 
medicine. USA had the highest share of 1814(28.4%) publications and received 
17779 Citations followed by Peoples Republic of China with 18623 Citations for 
986(15.5%) publications, Italy with 7418 Citations for 763(12%) publications, 
India with 3323 Citations for 617(9.7%) publications, UK with 7178 Citations for 
577 publications. The study found that China scored first position according to 
Citations followed by USA, Italy, UK and India. India has shared nearly 10% 
Publications at global level and 30% Publications compare with USA. It is also 
noted that 21 countries are registered more than 100 publications, the range of 
Citations are 611 to 18623 and 67 Countries registered the minimum of 10 
Publications out of 140. 15 countries recorded more than 1000 Citations, 25 
with more than 500 Citations and 50 with more than 100 Citations.  
 
Table 1 Geographical wise distribution of publications and Citations 
# Country Records % Citations  Country Records % Citations  
1 USA 1814 28.4 17779  Kenya 8 0.1 21  
2 Peoples R China 986 15.5 18623  Kuwait 8 0.1 47  
3 Italy 763 12.0 7418  Palestine 8 0.1 24  
4 India 617 9.7 3323  Bolivia 7 0.1 27  
5 UK 577 9.0 7178  Bulgaria 7 0.1 126  
6 Germany 323 5.1 3017  Ecuador 7 0.1 61  
7 Spain 307 4.8 2165  Peru 7 0.1 5  
8 France 282 4.4 3229  Bosnia & Herceg 6 0.1 2  
9 Canada 268 4.2 2150  Cameroon 6 0.1 39  
10 Australia 253 4.0 2608  DEM REP CONGO 6 0.1 37  
11 Iran 217 3.4 798  Kazakhstan 6 0.1 12  
12 Brazil 205 3.2 1297  Luxembourg 6 0.1 17  
13 Turkey 171 2.7 834  Sri Lanka 6 0.1 14  
14 Saudi Arabia 167 2.6 1081  Bahrain 5 0.1 1  
15 Switzerland 147 2.3 1911  Venezuela 5 0.1 36  
16 Netherlands 123 1.9 885  Libya 4 0.1 2  
17 Japan 119 1.9 611  Panama 4 0.1 7  
18 South Korea 119 1.9 1051  Trinidad Tobago 4 0.1 12  
19 Unknown 116 1.8 302  Uruguay 4 0.1 0  
20 Egypt 112 1.8 823  Albania 3 0.0 0  
21 Belgium 101 1.6 892  BELARUS 3 0.0 1  
22 South Africa 90 1.4 347  Cuba 3 0.0 2  
23 Sweden 89 1.4 317  Estonia 3 0.0 12  
24 Poland 85 1.3 628  Georgia 3 0.0 12  
25 Pakistan 82 1.3 275  Honduras 3 0.0 1  
26 Greece 73 1.1 620  Iceland 3 0.0 6  
27 Singapore 73 1.1 1306  Kyrgyzstan 3 0.0 1  
28 Israel 69 1.1 280  Malta 3 0.0 11  
29 Austria 65 1.0 745  Tanzania 3 0.0 3  
30 Taiwan 64 1.0 577  Zimbabwe 3 0.0 14  
31 Russia 59 0.9 323  Armenia 2 0.0 0  
32 Portugal 58 0.9 382  Azerbaijan 2 0.0 8  
33 Ireland 54 0.8 362  Barbados 2 0.0 1  
34 Denmark 53 0.8 435  Benin 2 0.0 0  
35 Bangladesh 52 0.8 284  Botswana 2 0.0 0  
36 Mexico 51 0.8 149  Costa Rica 2 0.0 10  
37 Malaysia 46 0.7 95  Jamaica 2 0.0 6  
38 Romania 40 0.6 225  Latvia 2 0.0 4  
39 Argentina 36 0.6 124  Lithuania 2 0.0 3  
40 Norway 35 0.5 379  Montenegro 2 0.0 9  
41 U Arab Emirates 33 0.5 124  Myanmar 2 0.0 0  
42 Nigeria 32 0.5 73  Namibia 2 0.0 0  
43 New Zealand 28 0.4 321  Papua N Guinea 2 0.0 4  
44 Qatar 28 0.4 111  Rep Congo 2 0.0 1  
45 Thailand 28 0.4 302  Rwanda 2 0.0 23  
46 Colombia 27 0.4 152  Sudan 2 0.0 9  
47 Czech Republic 26 0.4 302  Syria 2 0.0 3  
48 Croatia 22 0.3 189  Zambia 2 0.0 0  
49 Finland 20 0.3 40  Afghanistan 1 0.0 5  
50 Hungary 20 0.3 38  Anguilla 1 0.0 0  
51 Indonesia 20 0.3 50  Antigua & Barbu 1 0.0 0  
52 Serbia 20 0.3 34  Bhutan 1 0.0 0  
53 Chile 19 0.3 190  Brunei 1 0.0 10  
54 Lebanon 19 0.3 40  Burkina Faso 1 0.0 1  
55 Morocco 18 0.3 14  Comoros 1 0.0 0  
56 Nepal 18 0.3 53  Cote Ivoire 1 0.0 23  
57 Ghana 16 0.3 66  Eritrea 1 0.0 0  
58 Jordan 16 0.3 34  French Guiana 1 0.0 5  
59 Slovenia 16 0.3 137  Guinea Bissau 1 0.0 8  
60 Philippines 15 0.2 51  Laos 1 0.0 33  
61 Vietnam 15 0.2 50  Madagascar 1 0.0 0  
62 Ethiopia 14 0.2 12  Malawi 1 0.0 8  
63 Tunisia 13 0.2 65  Mali 1 0.0 26  
64 Slovakia 12 0.2 22  Mauritius 1 0.0 0  
65 Iraq 11 0.2 12  Mozambique 1 0.0 345  
66 Algeria 10 0.2 31  North Macedonia 1 0.0 1  
67 Cyprus 10 0.2 71  Senegal 1 0.0 23  
68 Uganda 10 0.2 50  Somalia 1 0.0 3  
69 Oman 9  0.1 42  St Lucia 1 0.0 5  
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Institution wise distribution of Citations 
Among all Institutions, the highly productive Institutions were: Harvard 
Med School from USA with 102 publications (1175 Citations), followed by 
Huazhong Univ Science & Technology with 102 publications (2913 Citations), 
University Milan with 82 publications (1430 citations), It noted that 30 Institutes 
are registered more than 30 Publications and 25 Institutions are recorded more 
than 1000 Citations. 
Table 2: Publications and Citation Impact of Institutions 
 Publication Impact   Citation Impact  
# Institution Records Citations   Institution Records Citations 
1 Harvard Med School 102 1175   Wuhan Univ 60 3813  
2 Huazhong Univ Science 
& Technology 
102 2913   Tsinghua Univ 24 3401  
3 University Milan 82 1430   Chinese Acad Med Sci 29 3131  
4 University Toronto 79 406   Huazhong Univ Sci & 
Technology  
102 2913  
5 Chinese Academic 
Science 
64 1438   Univ Oxford 63 2677  
6 Univ Oxford 63 2677   Peking Union Med Coll 5 2423  
7 Univ Washington 62 379   Beijing Univ Chinese 
Med 
34 2401  
8 Wuhan University 60 3813   Peking Univ 26 2365  
9 Univ Penn 58 386   Capital Med Univ 33 2292  
10 Univ Calif San 
Francisco 
56 1278   Univ Virginia 20 2277  
11 Columbia Univ 54 376   China Japan 
Friendship Hosp 
7 2210  
12 Univ Michigan 54 997   Univ Lancaster 5 2205  
13 Mayo Clin 52 501   Jin Yin Tan Hospital 2 1460  
14 Univ Sao Paulo 52 623   Chinese Acad Science 64 1438  
15 Univ Tehran Med 
Science 
52 135   Univ Milan 82 1430  
16 Zhejiang Univ 50 1281   Sun Yat Sen Univ 35 1376  
17 King Saud Univ 49 183   Zhejiang Univ 50 1281  
18 Univ British Columbia 48 361   Univ Calif San 
Francisco 
56 1278  
19 UCL 47 200   Harvard Med School 102 1175  
20 Univ Paris 47 326   Univ Zurich 23 1075  
21 Icahn School Med Mt 
Sinai 
46 929   Natl Univ Singapore 25 1049  
22 Kings College London 45 278   Univ Calif San Diego 37 1043  
23 NYU 45 551   Cent Hosp Wuhan 4 1039  
24 Emory Univ 44 562   Univ Queensland 39 1039  
25 Fudan Univ 44 713   ShanghaiTech Univ 8 1018  
26 Johns Hopkins Univ 44 214   Univ Michigan 54 997  
27 Monash Univ 44 684   Nankai Univ 5 940  
28 All India Inst Med Sci 43 99   Qingdao Univ 5 938  
29 Stanford Univ 43 473   Hebei Med Univ 5 930  
30 Brigham & Womens 
Hosp 
42 847   Icahn Sch Med Mt 
Sinai 
46 929  
 
 
Bibliographic Form wise distribution of Publications 
Table 3 illustrates the document wise distribution of publication in Covid-
19 Drugs and Medicine research during the study period. The maximum 3202 
of research papers were found in ‘Articles’ type documents, followed by 1490 of 
records were ‘Review’ type documents, 586 with Editorial Materials, 484 with 
Article; Early Access, 295 with Letter. It noted that 13 forms are covered in this 
field.  
Table 3: Bibliographic Form wise distribution of Publications and Citations 
# Document Type  Records Citations  
1 Article 3202 29918  
2 Review 1490 13997  
3 Editorial Material 586 3050  
4 Letter 295 2197  
5 News Item 49 177  
6 Article; Early Access 484 1687  
7 Article; Proceedings Paper 3  4  
8 Correction 7  20  
9 Correction; Early Access 1  0  
10 Editorial Material; Early Access 30 7  
11 Letter; Early Access 26 201  
12 Meeting Abstract 30 0  
13 Review; Early Access 175 153  
 
Highly Cited Source titles  
Table 4 gives the leading journals each with number of publications and 
Citations. The highly Cited journals are: NEW ENGLAND JOURNAL OF 
MEDICINE with 2623 Citations (ACPP is 163.93) for 16 Publications, NATURE 
with 1546 Citations (ACPP is 96.62) for 16 publications, JOURNAL OF 
BIOMOLECULAR STRUCTURE & DYNAMICS with 1476 Citations (ACPP is 9.11) 
for 162 publications, JAMA-JOURNAL OF THE AMERICAN MEDICAL 
ASSOCIATION with 1365 Citations (ACPP is 39.08) for 35 publications, and 
SCIENCE with 1197 Citations (ACPP is 74.81) for 16 publications. The study 
found that 8 source titles are registered more than 1000 Citations and Majorities 
of the publications are published in high impact Journals.  
Table 4: Highly Cited Source titles 
# Journal Records  Citations  Average 
Citations Per 
Paper 
1 NEW ENGLAND JOURNAL OF MEDICINE 16 2623  163.9375 
2 NATURE 16 1546  96.625 
3 JOURNAL OF BIOMOLECULAR STRUCTURE & 
DYNAMICS 
162 1476  
9.111111 
4 JAMA-JOURNAL OF THE AMERICAN MEDICAL 
ASSOCIATION 
35 1368  
39.08571 
5 SCIENCE 16 1197  74.8125 
6 INTERNATIONAL JOURNAL OF ANTIMICROBIAL 
AGENTS 
34 1046  
30.76471 
7 ALLERGY 8  1040  130 
8 MILITARY MEDICAL RESEARCH 6  1001  166.8333 
9 BIOSCIENCE TRENDS 9  976  108.4444 
10 JOURNAL OF MEDICAL VIROLOGY 41 891  21.73171 
11 LANCET 12 871  72.58333 
12 EMERGING MICROBES & INFECTIONS 13 762  58.61538 
13 ANTIVIRAL RESEARCH 9  715  79.44444 
14 JAMA CARDIOLOGY 4  648  162 
15 NATURE COMMUNICATIONS 16 631  39.4375 
16 PHARMACOLOGICAL RESEARCH 32 608  19 
17 JOURNAL OF INFECTION 8  590  73.75 
18 LIFE SCIENCES 24 572  23.83333 
19 JOURNAL OF PAIN AND SYMPTOM MANAGEMENT 58 507  8.741379 
20 INTERNATIONAL JOURNAL OF MOLECULAR 
SCIENCES 
43 483  
11.23256 
21 JOURNAL OF ADVANCED RESEARCH 1  443  443 
22 JOURNAL OF THROMBOSIS AND HAEMOSTASIS 7  443  63.28571 
23 SCIENCE OF THE TOTAL ENVIRONMENT 12 414  34.5 
24 CLINICAL CHEMISTRY AND LABORATORY MEDICINE 15 403  26.86667 
25 BMJ-BRITISH MEDICAL JOURNAL 38 400  10.52632 
26 CLINICAL IMMUNOLOGY 2  386  193 
27 JOURNAL OF CLINICAL MEDICINE 42 383  9.119048 
28 JAMA NETWORK OPEN 6  356  59.33333 
29 CIRCULATION RESEARCH 2  353  176.5 





Most Cited and Productive Authors 
Table 5 shows the rank list, the contributors who have registered highest 
number of Publications and Citations. Most Cited authors are: Zhang Y has 
contributed 43 articles (2706 Citations) and followed by Wang Y contributed 39 
articles (2627 Citations), Wang J contributed 32 articles (2021 Citations). It is 
noted that 70 authors contributed more than 10 Publications. The most cited 
authors are: Liu X with 2746 Citations for 12 papers followed by Zhang Y with 
2706 Citations for 43 papers and Wang Y with 2627 Citations for 39 papers. It 
noted that 71 authors received more than 1000 Citations, 309 authors with more 
than 500 Citations and 1031 authors with minimum of 100 Citations.  
Table:5 Most Cited and Productive Authors 
 Publication Impact  Citation Impact  
# Author Records Citations Author Records Author 
1 Zhang Y 43 2706  Liu X 12 2746  
2 Wang Y 39 2627  Zhang Y 43 2706  
3 Wang J 32 2021  Wang Y 39 2627  
4 Kumar S 31 131  Dong X 5 2371  
5 Liu Y 31 2256  Liu Y 31 2256  
6 Li Y 27 415  Zhou F 7 2230  
7 Li J 24 601  Wang C 14 2206  
8 Li L 22 308  Cao B 3 2205  
9 Wang L 22 704  Wang K 13 2200  
10 Zhang L 22 1527  Horby PW 4 2187  
11 Li H 21 1670  Hayden FG 2 2179  
12 Chen Y 19 897  Jaki T 2 2179  
13 Wang H 18 19  Li HD 2 2179  
14 Zhang J 18 61  Wang J 32 2021  
15 Kumar A 17 59  Guo L 2 2010  
16 Yang J 17 864  Wang JL 5 1858  
17 Chen J 16 574  Li H 21 1670  
18 Lippi G 16 479  Wu X 5 1646  
19 Yang L 16 145  Xie X 3 1621  
20 Lee J 15 164  Peng L 4 1541  
21 Sharma P 15 27  Zhang L 22 1527  
22 Sharma S 15 53  Tu S 2 1514  
23 Zhang X 15 800  Huang H 7 1502  
24 Kumar V 14 88  Zhou X 7 1497  
25 Liu C 14 344  Li K 3 1494  
26 Liu J 14 173  Xu J 9 1491  
27 Shi Y 14 645  Liu W 6 1490  
28 Wang C 14 2206  Wu J 13 1489  
29 Zhang M 14 117  Li X 10 1484  




Highly Cited Works  
Top 20 highly cited Covid-19 Drugs and Medicine publications during the 
period of study are listed in Table 6. The most frequently cited one is “Cao B, 
Wang Y, Wen D, Liu W, Wang JL, et al, A Trial of Lopinavir-Ritonavir in Adults 
Hospitalized with Severe Covid-19, NEW ENGLAND JOURNAL OF MEDICINE. 
2020 MAY 7; 382 (19): 1787-1799” with 1459 citations followed by Guo YR, Cao 
QD, Hong ZS, Tan YY, Chen SD, et al., The origin, transmission and clinical 
therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the 
status MILITARY MEDICAL RESEARCH. 2020 MAR 13; 7 (1): Art. No. 11 with 
915 Citations, Gao JJ, Tian ZX, Yang X, Breakthrough: Chloroquine phosphate 
has shown apparent efficacy in treatment of COVID-19 associated pneumonia in 
clinical studies, BIOSCIENCE TRENDS. 2020 FEB; 14 (1): 72-73 with 900 
Citations.  
Table 6: Highly Cited Works 
# Date / Author / Journal Countries Citations  Cited 
References  
1 1416 Cao B, Wang Y, Wen D, Liu W, Wang JL, et al. 
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-





1459 25  
2 1096 Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, et al., The origin, 
transmission and clinical therapies on coronavirus disease 2019 
(COVID-19) outbreak - an update on the status 
MILITARY MEDICAL RESEARCH. 2020 MAR 13; 7 (1): Art. No. 11  
China and 
Singapore 
915 105  
3 1065 Gao JJ, Tian ZX, Yang X, Breakthrough: Chloroquine phosphate 
has shown apparent efficacy in treatment of COVID-19 associated 
pneumonia in clinical studies, BIOSCIENCE TRENDS. 2020 FEB; 14 
(1): 72-73  
China 900 4  
4 1936 Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, et al. 
Clinical characteristics of 140 patients infected with SARS-CoV-2 in 
Wuhan, China, ALLERGY. 2020 JUL; 75 (7): 1730-1741  
China and 
Switzerland 
890 40  
5 1437 Wang YM, Zhang DY, Du GH, Du RH, Zhao JP, et al. 
Remdesivir in adults with severe COVID-19: a randomised, double-
blind, placebo-controlled, multicentre trial 




720 28  
6 1426 Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB 
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A 
Review, JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 
2020 MAY 12; 323 (18): 1824-1836  
USA 602 94  
7 1107 Ou XY, Liu Y, Lei XB, Li P, Mi D, et al., Characterization of spike 
glycoprotein of SARS-CoV-2 on virus entry and its immune cross-
reactivity with SARS-CoV 
NATURE COMMUNICATIONS. 2020 MAR 27; 11 (1): Art. No. 1620  
China 551 53  
8 2416 Gordon DE, Jang GM, Bouhaddou M, Xu JW, Obernier K, et al., A 
SARS-CoV-2 protein interaction map reveals targets for drug 
repurposing, NATURE. 2020 JUL 16; 583 (7816): 459-+  
USA, England 
and France 
521 85  
9 1696 Jin ZM, Du XY, Xu YC, Deng YQ, Liu MQ, et al. 
Structure of M-pro from SARS-CoV-2 and discovery of its inhibitors, 
NATURE. 2020 JUN; 582 (7811): 289-+  
China, USA 
and Australia 
513 43  
10 1288 Zhang C, Wu Z, Li JW, Zhao H, Wang GQ 
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor 
antagonist tocilizumab may be the key to reduce mortality, 
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2020 MAY; 
55 (5): Art. No. 105954  
China 487 57  
11 1209 Zhang LL, Lin DZ, Sun XYY, Curth U, Drosten C, et al. 
Crystal structure of SARS-CoV-2 main protease provides a basis for 
design of improved alpha-ketoamide inhibitors 
SCIENCE. 2020 APR 24; 368 (6489): 409-+  
Germany and 
China 
486 43  
12 2113 Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R 
COVID-19 infection: Origin, transmission, and characteristics of human 
coronaviruses, JOURNAL OF ADVANCED RESEARCH. 2020 JUL; 24: 
91-98  
China 443 85  
13 1509 Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM 
The FDA-approved drug ivermectin inhibits the replication of SARS-
CoV-2 in vitro, ANTIVIRAL RESEARCH. 2020 JUN; 178: Art. No. 
104787  
Australia 404 31  
14 1255 Zhang W, Zhao Y, Zhang FC, Wang Q, Li TS, et al. China 378 38  
The use of anti-inflammatory drugs in the treatment of people with 
severe coronavirus disease 2019 (COVID-19): The Perspectives of 
clinical immunologists from China 
CLINICAL IMMUNOLOGY. 2020 MAY; 214: Art. No. 108393  
15 2107 Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, et al. 
Cardiac Involvement in a Patient With Coronavirus Disease 2019 
(COVID-19), JAMA CARDIOLOGY. 2020 JUL; 5 (7): 819-824  
Italy 377 15  
16 1856 Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN 
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19, NEW 
ENGLAND JOURNAL OF MEDICINE. 2020 JUN 18; 382 (25): Art. No. 
e102  
USA 376 22  
17 1207 Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, et 
al., Effect of High vs Low Doses of Chloroquine Diphosphate as 
Adjunctive Therapy for Patients Hospitalized With Severe Acute 
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A 
Randomized Clinical Trial 
JAMA NETWORK OPEN. 2020 APR 24; 3 (4): Art. No. e208857  
Brazil and 
Spain 
345 29  
18 2212 Su H, Yang M, Wan C, Yi LX, Tang F, et al., Renal 
histopathological analysis of 26 postmortem fi ndings of patients with 




336 14  
19 1857 Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G 
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-
19, NEW ENGLAND JOURNAL OF MEDICINE. 2020 JUN 18; 382 (25): 
2431-2440  
Italy 327 30  
20 1797 Zhang P, Zhu LH, Cai JJ, Lei F, Qin JJ, et al. 
Association of Inpatient Use of Angiotensin-Converting Enzyme 
Inhibitors and Angiotensin II Receptor Blockers With Mortality Among 
Patients With Hypertension Hospitalized With COVID-19, 









FINDINGS AND CONCLUSION  
This work explores the “Covid-19 Drugs and Medicines: A Scientometric 
Mapping of Research Publications”, both in terms of the number of articles, the 
quality of the publication (Citation impact) and trend of research. Scientist are 
working actively to increase the number of research articles, their publication in 
high impact factor journals, collaborating with leading institutions, Countries, 
Hospitals and Research laboratories. USA, China, Italy, and India were the other 
leading countries contributing in terms of corresponding authors and total 
citations and Publications. It is note that Harvard Med School from USA with 
102 publications (1175 Citations), followed by Huazhong Univ Science & 
Technology with 102 publications (2913 Citations), University Milan with 82 
publications (1430 citations) lead to other Institutions in terms of publications 
and Citations. It found that researcher has published their paper in high impact 
journals like NEW ENGLAND JOURNAL OF MEDICINE (Impact Factor: 74.699), 
NATURE (Impact Factor: 42.778), JOURNAL OF BIOMOLECULAR STRUCTURE 
& DYNAMICS (Impact Factor: 4.986), JAMA-JOURNAL OF THE AMERICAN 
MEDICAL ASSOCIATION (Impact Factor: 45.540), SCIENCE (Impact Factor: 
41.845).  It attacks a high number of Citations over a short period of time and 
web of science indexed huge number of publications over the past year. 
Governments are committed to research, spending huge amount money for 
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